Pivonello, R., Fleseriu, M., Newell-Price, J., Bertagna, X., Findling, J., Shimatsu, A., Gu, F., Auchus, R., Leelawattana, R., Lee, E. J., Kim, J. H., Lacroix, A., Laplanche, A., O'Connell, P., Tauchmanova, L., Pedroncelli, A. M., Biller, B. M. K., & , (2020). efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. Lancet, 8(9), 748–761. http://access.bl.uk/ark:/81055/vdc_100106942930.0x00000a